197 related articles for article (PubMed ID: 35644801)
1. SARS-CoV-2 seroprevalence in healthcare workers and risk factors.
Weber S; Didelot A; Agrinier N; Peyrin-Biroulet L; Schvoerer E; Rabaud C; Jeulin H
Infect Dis Health; 2022 Nov; 27(4):203-210. PubMed ID: 35644801
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India.
Kataria S; Phogat R; Sharma P; Deswal V; Alam S; Singh M; Kumar K; Gupta V; Singh P; Dutt R; Sarma S; Saxena R; Trehan N
Natl Med J India; 2022; 35(4):219-220. PubMed ID: 36715047
[TBL] [Abstract][Full Text] [Related]
5. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Ladoire S; Rederstorff E; Goussot V; Parnalland S; Briot N; Ballot E; Truntzer C; Ayati S; Bengrine-Lefevre L; Bremaud N; Coudert B; Desmoulins I; Favier L; Fraisse C; Fumet JD; Hennequin A; Hervieu A; Ilie S; Kaderbhai C; Lagrange A; Martin N; Mazilu I; Mayeur D; Palmier R; Simonet-Lamm AL; Vincent J; Zanetta S; Arnould L; Coutant C; Bertaut A; Ghiringhelli F
Eur J Cancer; 2022 Apr; 165():13-24. PubMed ID: 35189537
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.
Schubl SD; Figueroa C; Palma AM; de Assis RR; Jain A; Nakajima R; Jasinskas A; Brabender D; Hosseinian S; Naaseh A; Hernandez Dominguez O; Runge A; Skochko S; Chinn J; Kelsey AJ; Lai KT; Zhao W; Horvath P; Tifrea D; Grigorian A; Gonzales A; Adelsohn S; Zaldivar F; Edwards R; Amin AN; Stamos MJ; Barie PS; Felgner PL; Khan S
BMC Infect Dis; 2023 May; 23(1):330. PubMed ID: 37194021
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 seroprevalence among healthcare workers.
Wiggen TD; Bohn B; Ulrich AK; Stovitz SD; Strickland AJ; Naumchik BM; Walsh S; Smith S; Baumgartner B; Kline S; Yendell S; Hedberg C; Beebe TJ; Demmer RT
PLoS One; 2022; 17(4):e0266410. PubMed ID: 35468153
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study.
Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A
BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 antibodies and reduced risk of reinfection through 6 months: a Danish observational cohort study of 44 000 healthcare workers.
Iversen K; Kristensen JH; Hasselbalch RB; Pries-Heje M; Nielsen PB; Knudsen AD; Fogh K; Norsk JB; Andersen O; Fischer TK; Juul Jensen CA; Torp-Pedersen C; Rungby J; Ditlev SB; Hageman I; Møgelvang R; Gybel-Brask M; Dessau RB; Sørensen E; Harritshøj L; Folke F; Sten C; Engel Møller ME; Benfield T; Ullum H; Jørgensen CS; Erikstrup C; Ostrowski SR; Nielsen SD; Bundgaard H
Clin Microbiol Infect; 2022 May; 28(5):710-717. PubMed ID: 34543759
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S; Dafni U; Lamoth F; Tsourti Z; Lobritz MA; Regina J; Bressin P; Senn L; Grandbastien B; Andre C; Fenwick C; D'Acremont V; Croxatto A; Guilleret I; Greub G; Manuel O; Calandra T; Pantaleo G; Lazor-Blanchet C;
BMJ Open; 2021 Jul; 11(7):e049232. PubMed ID: 34226231
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland.
Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C
BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
[TBL] [Abstract][Full Text] [Related]
15. Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.
Galanis P; Kaitelidou D; Prezerakos P; Kotsiopoulos I; Siskou O; Konstantakopoulou O; Hadjichristodoulou C; Tsiodras S
Public Health; 2021 Sep; 198():223-229. PubMed ID: 34482100
[TBL] [Abstract][Full Text] [Related]
16. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.
Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö
Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study.
Taher WT; Bawazir AA; Sallam TA; Alsurimi K
BMC Infect Dis; 2023 Nov; 23(1):761. PubMed ID: 37932664
[TBL] [Abstract][Full Text] [Related]
19. Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff.
Bahrs C; Kimmig A; Weis S; Ankert J; Hagel S; Maschmann J; Stallmach A; Steiner A; Bauer M; Behringer W; Baier M; Kesselmeier M; Richert C; Zepf F; Walter M; Scherag A; Kiehntopf M; Löffler B; Pletz MW
Transbound Emerg Dis; 2022 Mar; 69(2):720-730. PubMed ID: 33605549
[TBL] [Abstract][Full Text] [Related]
20. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.
Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B
West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
